The outcome of the BSP121 study to establish batches 4 and 5 of the European Pharmacopoeia Heparin Low-Molecular-Mass for Calibration Chemical Reference Substance (CRS) has been published in the online journal Pharmeuropa Bio & Scientific Notes and is referenced in Medline/PubMed® (Pharmeur Bio Sci Notes. 2023;2023:81-111). The study was run within the framework of the Biological Standardisation Programme (BSP) of the Council of Europe and the Commission of the European Union.
See also: